Roche to lay off 300 to 400 employees in product development jobs

July 5, 2021

Top 10 Innovations in Target Identification in Drug Development

September 3, 2026

Clinical Trial Evaluating Monkeypox Vaccine enter Phase III

September 20, 2022

Must Read

Top 10 Technologies Improving Patient Retention

November 3, 2026

Building AI-Ready Data Platforms in Life Sciences

November 3, 2026

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

November 3, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Novartis Reports Late-Stage Trial Setbacks for Del-Desiran and Pelacarsen

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Top 10 Technologies Improving Patient Retention

Building AI-Ready Data Platforms in Life Sciences

Top 10 Digital Capabilities Separating Industry Leaders

Top 10 Metrics Clinical Operations Leaders Should Track

Tag: Tulisokibart

Merck Reports Positive Phase 3 Result for Tulisokibart in Ulcerative Colitis

Editor Picks

Roche to lay off 300 to 400 employees in product development jobs

Top 10 Innovations in Target Identification in Drug Development

Clinical Trial Evaluating Monkeypox Vaccine enter Phase III

Must Read

Top 10 Technologies Improving Patient Retention

Building AI-Ready Data Platforms in Life Sciences

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Hot Topics

About Us

Follow Us